[ACRS] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
04-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 8.09%
YoY- 80.73%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 1,824 1,777 1,580 1,449 2,046 1,407 1,095 40.56%
PBT -18,161 -28,754 -13,779 -10,659 -11,570 -15,328 -19,177 -3.56%
Tax 4,800 16,439 -182 -591 27 -318 -32,181 -
NP -18,161 -28,754 -13,173 -10,659 -11,597 -15,586 -18,594 -1.55%
Tax Rate - - - - - - - -
Total Cost 19,985 30,531 14,753 12,108 13,643 16,993 19,689 1.00%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -995.67 -1,618.12 -833.73 -735.61 -566.81 -1,107.75 -1,698.08 -29.96%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.34 -0.57 -0.30 -0.25 -0.28 -0.37 -0.45 -17.05%
EPS Diluted -0.34 -0.57 -0.30 -0.25 -0.28 -0.37 -0.45 -17.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.